Research entry
Sermorelin
Research overview
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of endogenous GHRH. It was previously FDA-approved for pediatric growth hormone deficiency. Laboratory and clinical research has studied its effects on pituitary growth hormone secretion and downstream IGF-1 signaling in research models.
Research articles
All research cited here is drawn from peer-reviewed scientific literature and provided for informational and educational purposes only. PureChain products are sold strictly for laboratory and research use — not for human consumption, therapeutic use, or clinical application of any kind. Nothing on this page is medical advice.